06 Mar 2015

Casodex 50 (Bicalutamide) - United Kingdom

ATC: L02BB
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONE ANTAGONISTS AND RELATED AGENTS
ANTI-ANDROGENS
Casodex 50 mg Film-coated Tablets

Generic Matches for Bicalutamide (2)
Casodex 50 mg Film-coated Tablets
Casodex 150 mg Film-coated Tablets

Last Updated on 06 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Casodex 50 mg Film-coated Tablets Indication

Treatment of advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.

 

Casodex 50 mg Film-coated Tablets Generic Name

Bicalutamide

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Casodex 50 mg Film-coated Tablets (external site)

Related Learning Zones

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

Selected content related to Casodex 50 (Bicalutamide)

Journals

Guidelines

Casodex 50 Marketing Information

Casodex 50 Generic Name
Bicalutamide
Marketing Company
AstraZeneca UK Limited
Drug Type
POM
Date of Issue, Marketing Authority 18/06/2000

Related Drugs - Oncology

Back to top